How to manage a sickle cell crisis in the 3rd trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Sickle Cell Crisis in the 3rd Trimester of Pregnancy

Pregnant women with sickle cell disease experiencing a crisis in the third trimester should be managed in a specialized obstetric unit with expertise in sickle cell disease, with prompt pain management, adequate hydration, oxygen therapy if hypoxemic, and consideration of transfusion therapy based on clinical severity. 1, 2

Initial Assessment and Management

Immediate Interventions

  • Pain Management:

    • Implement a tiered approach based on pain severity
    • For moderate to severe pain: opioid analgesia (e.g., morphine 5-10 mg IV/SC)
    • Consider epidural analgesia, particularly if there is lower body pain or opioid tolerance 1
  • Hydration:

    • Administer IV fluids to correct dehydration
    • Monitor fluid balance carefully to avoid fluid overload
  • Oxygen Therapy:

    • Provide supplemental oxygen if SpO2 < 94%
    • Monitor oxygen saturation continuously

Laboratory Assessment

  • Complete blood count to assess baseline hemoglobin and detect worsening anemia
  • Reticulocyte count to evaluate bone marrow response
  • Comprehensive metabolic panel to assess renal function
  • Blood cultures if febrile
  • Group and crossmatch for potential transfusion 1

Transfusion Considerations

Indications for Transfusion

  • Severe anemia (Hb < 70 g/L)
  • Acute chest syndrome
  • Stroke or other severe complications
  • Worsening clinical status despite supportive care 1

Transfusion Protocol

  • For simple transfusion: target Hb of 100 g/L
  • For exchange transfusion: aim to reduce HbS percentage to < 30%
  • Blood should ideally be < 10 days old for simple transfusion and < 8 days old for exchange transfusion
  • Ensure donor red cells are HbS negative and compatible for ABO, Rh, and Kell antigens 1

Management of Specific Complications

Acute Chest Syndrome

  • Low threshold for diagnosis (new pulmonary infiltrate + chest pain, fever, tachypnea, wheezing, or cough)
  • Broad-spectrum antibiotics
  • Consider exchange transfusion
  • Early ICU consultation 2

Infection

  • Prompt administration of broad-spectrum antibiotics for suspected infection
  • Low threshold for hospital admission 2

Obstetric Considerations

Fetal Monitoring

  • Continuous electronic fetal monitoring during crisis
  • Ultrasound assessment of fetal growth and well-being
  • Consider antenatal corticosteroids if preterm delivery is anticipated

Delivery Planning

  • Regional anesthesia is preferred for cesarean section if needed
  • Avoid general anesthesia when possible due to increased risks
  • If general anesthesia is required, ensure effective oxygenation during intubation 1

Postpartum Care

  • Continue close monitoring for at least 48 hours after delivery
  • Maintain hydration and pain control
  • Thromboprophylaxis with low molecular weight heparin
  • Early mobilization when pain controlled 1

Common Pitfalls to Avoid

  • Delayed pain management: Pain should be treated promptly and adequately to prevent worsening of crisis
  • Inadequate hydration: Dehydration can worsen sickling
  • Failure to recognize acute chest syndrome: Maintain high index of suspicion for this life-threatening complication
  • Overlooking infection: Pregnant women with SCD are at increased risk of infections
  • Delaying transfusion when indicated: Early consultation with hematology is essential

Multidisciplinary Approach

  • Involve obstetrics, hematology, anesthesiology, and critical care teams
  • Clear communication regarding management plan
  • Early ICU consultation for severe cases 1, 2

The management of sickle cell crisis in the third trimester requires prompt intervention to reduce maternal and fetal morbidity and mortality. While the Association of Anaesthetists guideline 1 provides comprehensive recommendations for management, the American Society of Hematology 1 notes that transfusion decisions should be individualized based on clinical severity and patient history. With appropriate management in specialized centers, maternal mortality has significantly decreased in recent years 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sickle Cell Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.